Adoptive transfer of iNKT cells has the added advantage of reversing the defective iNKT cell IFN-γ production commonly observed in cancer patients, which is known to be important for promoting antitumor immune responses (45, 49, 50). This evidence concerns the gene IFNG and cancer.